
Jonvir-ET Tablet
Marketer
Johnlee Pharmaceuticals Pvt Ltd
Salt Composition
Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg) + Efavirenz (600mg)
Overview Jonvir-ET Tablet
Jonvir-ET tablets combine antiretroviral drugs to combat HIV (human immunodeficiency virus) infection. This medication is used to manage HIV and AIDS (acquired immunodeficiency syndrome) by strengthening the immune system's response. Jonvir-ET inhibits HIV replication, lessening the chance of related complications and extending life expectancy. For best results, take the medication on an empty stomach, ideally before sleep, consistently at the same time each day. Missed doses may hinder treatment; complete the prescribed course as directed by your physician. Common side effects, including fatigue, headaches, nausea, dizziness, sleep disturbances, rash, diarrhea, nasal congestion, impaired concentration, abnormal dreams, pain, depression, and cough, typically resolve within 2-4 weeks. Report persistent or bothersome effects to your doctor. Drowsiness may occur; avoid driving or operating machinery. Alcohol should be avoided as it can worsen side effects. Consult your doctor before starting treatment if you are pregnant, breastfeeding, or have pre-existing conditions like kidney or liver disease. Pre- and post-treatment lab tests may be necessary to monitor blood counts and organ function. If HIV-positive, breastfeeding and sharing personal items should be avoided; discuss safe sex practices with your doctor to prevent transmission.
Uses of Jonvir-ET Tablet
Managing HIV disease
Major Benefits of Jonvir-ET Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Jonvir-ET Tablet on an empty stomach.
Common Side effects of Jonvir-ET Tablet:
- Headache
- Dizziness
- Nausea
- Insomnia (difficulty in sleeping)
- Weakness
- Depression
- Diarrhea
- Rash
- Pain
- Fever
- Decreased white blood cell count (neutrophils)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Back pain
- Abdominal pain
- Anxiety
- Vomiting
- Joint pain
- Pneumonia
- Dyspepsia
- Muscle pain
- Lipodystrophy (skin thickening or pits at the injection site)
- Hypercholesterolemia (high cholesterol)
- Increased triglyceride level in blood
- Elevated creatinine kinase
- Elevated levels of serum amylase
- Blood in urine
- Increased transaminase level in blood
- Cough
- Impaired concentration
- Abnormal dreams
How to use Jonvir-ET Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Jonvir-ET Tablet on an empty stomach.
How Jonvir-ET Tablet works:
Jonvir-ET tablets contain a triple antiviral blend of lamivudine, tenofovir disoproxil fumarate, and efavirenz. This medication functions by hindering HIV replication, thus lowering the viral load. Consequently, it elevates the CD4 count, bolstering the immune system's infection-fighting capabilities.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when drinking alcohol while taking Jonvir-ET Tablets. Seek your physician's guidance.
PregnancyCONSULT YOUR DOCTOR
Using Jonvir-ET Tablets during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Use of Jonvir-ET Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Driving should be avoided if taking Jonvir-ET Tablets causes drowsiness, blurred vision, dizziness, or reduced alertness.
KidneySAFE IF PRESCRIBED
Use of Jonvir-ET Tablet in patients with kidney disease appears to be generally safe. Existing evidence indicates dose modification may not be necessary, though this is based on limited information. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Jonvir-ET Tablets in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may not be necessary, however, physician consultation is advised.
What if you forget to take Jonvir-ET Tablet :
Should you forget a Jonvir-ET Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Jonvir-ET Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
